We are live on ! Find out more
N

Nuveen Portfolio holdings

AUM $369B
1-Year Est. Return 31.66%
This Fund
S&P 500
This Quarter Est. Return
+10%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$264B
AUM Growth
+$16.6B
Cap. Flow
-$3.28B
Cap. Flow %
-1.24%
Top 10 Hldgs %
18.75%
Holding
3,331
New
118
Increased
1,090
Reduced
1,840
Closed
95

Top Sells

Rank Stock Value
1
CSCO icon
Cisco
CSCO
+$474M
2
CELG
Celgene Corp
CELG
+$421M
3
AVGO icon
Broadcom
AVGO
+$411M
4
NFLX icon
Netflix
NFLX
+$387M
5
AAPL icon
Apple
AAPL
+$372M

Sector Composition

Rank Sector Weight
1 Technology 20.51%
2 Financials 14.64%
3 Healthcare 13.3%
4 Consumer Discretionary 10.29%
5 Communication Services 9.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMNB
2551
DELISTED
American National Bankshares Inc
AMNB
$1.44M ﹤0.01%
36,472
DX
2552
Dynex Capital
DX
$3.21B
$1.44M ﹤0.01%
85,006
-70,270
-45% -$1.13M
ASC icon
2553
Ardmore Shipping
ASC
$683M
$1.44M ﹤0.01%
158,617
-45,192
-22% -$376K
LCI
2554
DELISTED
Lannett Company, Inc.
LCI
$1.44M ﹤0.01%
40,672
-90
-0.2% -$3.66K
SWTX
2555
DELISTED
SpringWorks Therapeutics
SWTX
$1.43M ﹤0.01%
+37,240
New +$872K
AMRC icon
2556
Ameresco
AMRC
$1.36B
$1.43M ﹤0.01%
81,789
-530
-0.6% -$8.34K
TEO icon
2557
Telecom Argentina
TEO
$5.96B
$1.43M ﹤0.01%
125,900
-2,500
-2% -$25.1K
CVM icon
2558
CEL-SCI Corp
CVM
$30.1M
$1.43M ﹤0.01%
5,202
-15
-0.3% -$3.54K
ERII icon
2559
Energy Recovery
ERII
$443M
$1.43M ﹤0.01%
145,836
-421
-0.3% -$3.88K
PZN
2560
DELISTED
Pzena Investment Management, Inc. Class A
PZN
$1.43M ﹤0.01%
165,555
-6,852
-4% -$59K
CALA
2561
DELISTED
Calithera Biosciences, Inc
CALA
$1.42M ﹤0.01%
12,428
-16,021
-56% -$1.2M
PFIS icon
2562
Peoples Financial Services
PFIS
$707M
$1.41M ﹤0.01%
28,046
TAST
2563
DELISTED
Carrols Restaurant Group, Inc.
TAST
$1.41M ﹤0.01%
199,754
-157,300
-44% -$1.15M
BHR
2564
Braemar Hotels & Resorts
BHR
$142M
$1.41M ﹤0.01%
125,368
-2,191
-2% -$20.5K
CALX icon
2565
Calix
CALX
$2.39B
$1.41M ﹤0.01%
175,587
-22,100
-11% -$165K
PAR icon
2566
PAR Technology
PAR
$735M
$1.4M ﹤0.01%
45,588
-112
-0.2% -$3.06K
FRPH icon
2567
FRP Holdings
FRPH
$421M
$1.4M ﹤0.01%
56,218
-2,256
-4% -$56.7K
BREW
2568
DELISTED
Craft Brew Alliance, Inc.
BREW
$1.39M ﹤0.01%
84,332
-91,430
-52% -$1.14M
REAL icon
2569
The RealReal
REAL
$1.5B
$1.39M ﹤0.01%
73,638
+28,456
+63% +$545K
CZNC icon
2570
Citizens & Northern Corp
CZNC
$455M
$1.38M ﹤0.01%
48,985
-367
-0.7% -$9.56K
PARAA
2571
DELISTED
Paramount Global Class A
PARAA
$1.38M ﹤0.01%
+30,856
New +$1.31M
CRCM
2572
DELISTED
CARE.COM, INC.
CRCM
$1.38M ﹤0.01%
91,965
+15,567
+20% +$187K
NWPX icon
2573
NWPX Infrastructure Inc
NWPX
$1.15B
$1.38M ﹤0.01%
41,330
+4,266
+12% +$135K
REV
2574
DELISTED
Revlon, Inc.
REV
$1.38M ﹤0.01%
64,272
+14,926
+30% +$360K
PTGX icon
2575
Protagonist Therapeutics
PTGX
$9.44B
$1.37M ﹤0.01%
194,437
+43,906
+29% +$436K

Similar funds

Nuveen's Q4 2019 Portfolio in Review

As of Q4 2019, Nuveen held 3,331 positions worth $264B, up 6.7% from $247B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Nuveen's Q4 2019 filing shows 118 new, 1,090 increased, 1,840 reduced and 95 closed positions. Its largest new stake was iShares iBoxx $ Investment Grade Corporate Bond ETF: 8,077,161 shares worth $1.03B. The largest sale was Cisco, an estimated $474M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.

  • Nuveen's largest Q4 2019 buy was iShares iBoxx $ Investment Grade Corporate Bond ETF: 8,077,161 shares worth $1.03B.
  • Nuveen added most to Bristol-Myers Squibb in Q4 2019, an estimated $649M increase.
  • Nuveen's biggest Q4 2019 reduction was Cisco, cutting an estimated $474M.
  • Nuveen fully exited Celgene Corp in Q4 2019, selling an estimated $421M.
  • Nuveen's ten largest holdings make up 19% of its $264B portfolio in Q4 2019.
  • Nuveen opened 118 new positions and closed 95 in Q4 2019.
  • Nuveen's portfolio value rose 6.7% quarter-over-quarter to $264B.

Based on Nuveen's 13F filing for Q4 2019, filed 14 Feb 2020.